Bio Protocol funding of $6.9 million enables an AI-native DeSci platform that compresses drug discovery by combining blockchain-based funding, decentralized governance and automated “BioAgents.” The raise aims to accelerate experiments, tokenize IP, and align researchers and community capital for faster, transparent science.
Raised $6.9M to scale an AI-native DeSci platform
Uses tokenized IP, staking and community funding to accelerate drug discovery
Backers include Maelstrom Fund, Animoca Brands and Moonrock Capital; onchain records credit contributors
Bio Protocol funding: $6.9M raised to scale AI-native DeSci research — learn how to participate and what it means for drug discovery. Read now.
Bio Protocol secured $6.9 million in funding from Maelstrom Fund, Animoca Brands and other investors to advance science using AI and crypto.
‘,
‘
🚀 Advanced Trading Tools Await You!
Maximize your potential. Join now and start trading!
‘,
‘
📈 Professional Trading Platform
Leverage advanced tools and a wide range of coins to boost your investments. Sign up now!
‘
];
var adplace = document.getElementById(“ads-bitget”);
if (adplace) {
var sessperindex = parseInt(sessionStorage.getItem(“adsindexBitget”));
var adsindex = isNaN(sessperindex) ? Math.floor(Math.random() * adscodesBitget.length) : sessperindex;
adplace.innerHTML = adscodesBitget[adsindex];
sessperindex = adsindex === adscodesBitget.length – 1 ? 0 : adsindex + 1;
sessionStorage.setItem(“adsindexBitget”, sessperindex);
}
})();
By COINOTAG — Published: 2025-09-18 • Updated: 2025-09-18
What is Bio Protocol funding and why does it matter?
Bio Protocol funding is a $6.9 million investment round backing an AI-native decentralized science (DeSci) platform that merges blockchain incentives with automated research agents to shorten the drug discovery timeline. The capital will expand Bio Protocol’s framework for community-driven, tokenized research and onchain attribution.
How does the DeSci platform speed up research?
Bio Protocol compresses traditional pipelines by combining decentralized funding with AI-powered agents called “BioAgents.” These agents propose hypotheses, coordinate onchain wallets and direct community-raised capital into experiments. Each milestone is recorded onchain to ensure immutable attribution and transparent progress tracking.
Who invested in the round and what are their perspectives?
Investors in the $6.9 million round include Maelstrom Fund, Animoca Brands and Moonrock Capital. Maelstrom founder Arthur Hayes called Bio Protocol a potential “category-defining launchpad” that could establish an AI-native research market. Simon Dedic of Moonrock Capital emphasized the project’s potential to address systemic incentive failures in academic science.
‘,
‘
🔒 Secure and Fast Transactions
Diversify your investments with a wide range of coins. Join now!
‘,
‘
💎 The Easiest Way to Invest in Crypto
Dont wait to get started. Click now and discover the advantages!
‘
];
var adplace = document.getElementById(“ads-binance”);
if (adplace) {
var sessperindex = parseInt(sessionStorage.getItem(“adsindexBinance”));
var adsindex = isNaN(sessperindex) ? Math.floor(Math.random() * adscodesBinance.length) : sessperindex;
adplace.innerHTML = adscodesBinance[adsindex];
sessperindex = adsindex === adscodesBinance.length – 1 ? 0 : adsindex + 1;
sessionStorage.setItem(“adsindexBinance”, sessperindex);
}
})();
Bio Protocol uses tokenized intellectual property, staking systems and loyalty rewards to align researchers, investors and community contributors. These crypto-native incentives aim to reduce grant delays and misaligned academic incentives by tying funding and rewards to measurable onchain milestones.
Bio Protocol’s model faces regulatory, reproducibility and IP-clarity challenges common to DeSci and biotech. Community-driven experiments still require rigorous validation and safety oversight. The platform must demonstrate reproducible outcomes before large-scale adoption.
Participation routes include proposing experiments, staking tokens to fund projects, joining governance votes, and running or auditing BioAgents. The platform documents each contribution onchain to ensure reward eligibility and credit.
‘
];
var adplace = document.getElementById(“ads-htx”);
if (adplace) {
var sessperindex = parseInt(sessionStorage.getItem(“adsindexHtx”));
var adsindex = isNaN(sessperindex) ? Math.floor(Math.random() * adscodesHtx.length) : sessperindex;
adplace.innerHTML = adscodesHtx[adsindex];
sessperindex = adsindex === adscodesHtx.length – 1 ? 0 : adsindex + 1;
sessionStorage.setItem(“adsindexHtx”, sessperindex);
}
})();
Source: https://en.coinotag.com/bio-protocol-6-9m-raise-may-fuel-ai-native-desci-ecosystem-around-ethereum/